Factor V Leiden: Prevalence and thromboembolic complications after total hip replacement in Ireland

Irish Journal of Medical Science

Volumn 176, Issue 4, 2007, Pages 273-277

  Bowler, D J M ^a,b   Bale, E ^a   O'Byrne, J ^a  

^a CAPPAGH NATIONAL ORTHOPAEDIC HOSPITAL   (Ireland)

^b NONE   (Ireland)

Author keywords

Factor V Leiden; Total hip replacement; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGED; ARTICLE; COMPRESSION THERAPY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FISHER EXACT TEST; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; IRELAND; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; POSTOPERATIVE THROMBOSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; THROMBOGENESIS; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS;

AGED; ANALYSIS OF VARIANCE; ARTHROPLASTY, REPLACEMENT, HIP; CASE-CONTROL STUDIES; FACTOR V; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRELAND; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PREVALENCE; PROBABILITY; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 36549060164     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-007-0095-x     Document Type: Article

References (21)

1. Clagett GP, Anderson FA Jr, Heit J, Levine MN, Wheeler HB (1995) Prevention of venous thromboembolism. Chest 108(4 Suppl):312S-334S
2. Manganelli D, Palla A, Donnamaria V, Giuntini C (1995) Clinical features of pulmonary embolism. Doubts and certainties. Chest 107(1 Suppl):25S-32S
3. Della Valle CJ, Issack PS, Baitner A, Steiger DJ, Fang C, Di Cesare PE (2001) The relationship of the Factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty. BMC Musculoskelet Disord 2(1):1
4. Woolson ST, Zehnder JL, Maloney WJ (1998) Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty. J Arthroplasty 13(2):207-210
5. Eckman MH, Erban JK, Singh SK, Kao GS (2003) Screening for the risk for bleeding or thrombosis. Ann Intern Med 138(3):W15-W24
6. Adcock DM, Fink L, Marlar RA (1997) A laboratory approach to the evaluation of hereditary hypercoagulability. Am J Clin Pathol 108(4):434-449
7. Dahlback B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90(3):1004-1008
8. Bertina RM, Koeleman BP, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369(6475):64-67
9. Voorberg J, Roelse J, Koopman R et al (1994) Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet 343(8912):1535-1536
10. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B (1994) Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343(8909):1361-1362
11. Zoller B, Dahlback B (1994) Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343(8912):1536-1538
12. Press RD, Bauer KA, Kujovich JL, Heit JA (2002) Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med Nov 126(11):1304-1318
13. Heijmans BT, Westendorp RG, Knook DL, Kluft C, Slagboom PE (1998) The risk of mortality and the Factor V Leiden mutation in a population-based cohort. Thromb Haemost 80(4):607-609
14. Lindahl TL, Lundahl TH, Nilsson L, Andersson CA (1999) APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee-a prospective study. Thromb Haemost 81(1):18-21
15. Lowe GD, Haverkate F, Thompson SG et al (1999) Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT Study. European Concerted Action on Thrombosis. Thromb Haemost 81(6):879-886
16. Philipp CS, Dilley A, Saidi P et al (1998) Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost 80(6):869-873
17. Ryan DH, Crowther MA, Ginsberg JS, Francis CW (1998) Relation of Factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med 128(4):270-276
18. Joseph JE, Low J, Courtenay B, Neil MJ, McGrath M, Ma D (2005) A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty. Br J Haematol 129(1):87-92
19. Wahlander K, Larson G, Lindahl TL et al (2002) Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost 87(4):580-585
20. Bounameaux H (2000) Factor V Leiden paradox: Risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 356(9225):182-183
21. Perrier A (2000) Deep vein thrombosis and pulmonary embolism: A single disease entity with different risk factors? Chest 118(5):1234-1236